MD, A., A, T., BC, C., F, S., & Y, Z. (2025). Multiple sclerosis and sarcopenia: Analysis of population-level prevalence and key risk factors from the UK Biobank. Multiple sclerosis and related disorders, 102, 106629. https://doi.org/10.1016/j.msard.2025.106629
Chicago Style (17th ed.) CitationMD, Allen, Thompson A, Clark BC, Schumacher F, and Zhang Y. "Multiple Sclerosis and Sarcopenia: Analysis of Population-level Prevalence and Key Risk Factors from the UK Biobank." Multiple Sclerosis and Related Disorders 102 (2025): 106629. https://doi.org/10.1016/j.msard.2025.106629.
MLA (9th ed.) CitationMD, Allen, et al. "Multiple Sclerosis and Sarcopenia: Analysis of Population-level Prevalence and Key Risk Factors from the UK Biobank." Multiple Sclerosis and Related Disorders, vol. 102, 2025, p. 106629, https://doi.org/10.1016/j.msard.2025.106629.